Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)

被引:2
|
作者
Uttarilli, Anusha [1 ,2 ]
Pasumarthi, Divya [1 ]
Ranganath, Prajnya [1 ,3 ]
Dalal, Ashwin B. [1 ]
机构
[1] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, 4-1-714 Tuljaguda Complex,Mozamzahi Rd, Hyderabad 500001, Telangana, India
[2] Manipal Univ, Grad Studies, Manipal, Karnataka, India
[3] Nizams Inst Med Sci, Dept Med Genet, Hyderabad, Telangana, India
关键词
Molecular analysis; Mucopolysaccharidoses type VI; Novel mutation; Functional characterization; Pathogenic variant; Genotype-phenotype correlation; MISSENSE MUTATIONS; GENE; ARSB; N-ACETYLGALACTOSAMINE-4-SULFATASE; IDENTIFICATION; MUTANT;
D O I
10.1016/j.gene.2016.11.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MPS VI is an autosomal recessive disorder which occurs due to the deficiency of N-acetyl galactosamine-4-sulfatase (Arylsulfatase B - ARSB) involved in catabolism of dermatan sulfate resulting from disease-causing variations in the ARSB gene. Human Gene Mutation Database (HGMD) search revealed 200 different mutations in ARSB worldwide. In the present study we carried out molecular and functional analyses to characterize the mutations reported by us in Indian population. Mutation analysis of 19 MPS VI patients revealed presence of a total of 15 different mutations of which twelve were novel [p.Asp53Asn (c.157G>A; p.D53N), p.Leu98Arg (c.293T>G; p.L98R), p.Tyr103Serfs*9 (c.306_312delCTACCAG+146del; p.Y103Sfs*9), p.Phe166Leufs*18 (c.496delT; p.F166Lfs*18), p.Ile220Serfs*5 (c.659_660delTA; p.I220Sfs*5), p.Ile350Phe (c.1048A>T; p.I350F), p.Trp353* (c.1059G>A; p.W353*), p.His393Arg (c.1178A>G; p.H393R), p.Ser403Tyrfs* (c.1208delC; p.S403Yfs*), p.Pro445Leu (c.1334C>T; p.P445L), p.Trp450Leu (c.1349G>T; p.W450L) and p.Trp450Cys (c.1350G>C; p.W450C)] and three were known mutations [p.Asp54Asn (c.160G>A; p.D54N), p.Ala237Asp (c.710C>A; p.A237D) and p.Ser320Arg (c.960C>G; p.S320R)]. Functional characterization using site-directed mutagenesis followed by cell transfection assays, immunoblot, reverse transcriptase PCR and immunofluorescence studies for the putative pathogenic variants detected in our MPS VI patient cohort helped us to confirm the pathogenic potential of the variants in ARSB. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 50 条
  • [1] MAROTEAUX-LAMY MUCOPOLYSACCHARIDOSIS (TYPE-VI) AND ARYLSULFATASE B DEFICIENCY
    DIFERRAN.N
    SINGH, J
    DONNELLY, PV
    GNIOTSZU.J
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1520 - 1520
  • [2] Maroteaux-Lamy syndrome:: Functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene
    Garrido, Elena
    Cormand, Bru
    Hopwood, John J.
    Chabas, Amparo
    Grinberg, Daniel
    Vilageliu, Lluisa
    MOLECULAR GENETICS AND METABOLISM, 2008, 94 (03) : 305 - 312
  • [3] MUCOPOLYSACCHARIDOSIS-VI MAROTEAUX-LAMY SYNDROME - ARYLSULFATASE B-DEFICIENT MUCOPOLYSACCHARIDOSIS IN THE SIAMESE CAT
    HASKINS, ME
    JEZYK, PF
    DESNICK, RJ
    PATTERSON, DF
    AMERICAN JOURNAL OF PATHOLOGY, 1981, 105 (02): : 191 - 193
  • [4] Clinical Experiments in Patients with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Er, Esra
    Canda, Ebru
    Ucar, Sema Kalkan
    Sozmen, Eser
    Coker, Mahmut
    JOURNAL OF PEDIATRIC RESEARCH, 2016, 3 (02) : 82 - 85
  • [5] Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
    Golda, Adam
    Jurecka, Agnieszka
    Tylki-Szymanska, Anna
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 6 - 11
  • [6] Craniovertebral abnormalities in Type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome)
    Thorne, JA
    Javadpour, M
    Hughes, DG
    Wraith, E
    Cowie, RA
    NEUROSURGERY, 2001, 48 (04) : 849 - 852
  • [7] Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
    Suh, Soon Hak
    Okutani, Ryu
    Nakasuji, Masato
    Nakata, Kazuo
    JOURNAL OF ANESTHESIA, 2010, 24 (06) : 945 - 948
  • [8] Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) - a case report
    Jurecka, Agnieszka
    Rozdzynska, Agnieszka
    Marucha, Jolanta
    Czartoryska, Barbara
    Tylki-Szymanska, Anna
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2010, 6 (02): : 151 - 155
  • [9] Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Karir, Aneesh
    Geraghty, Michael
    Vassilyadi, Michael
    Doja, Asif
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2018, 8
  • [10] Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients
    Beth Leiro
    Dawn Phillips
    Melanie Duiker
    Paul Harmatz
    Sharon Charles
    Orphanet Journal of Rare Diseases, 16